IC 106-2024: Ulnar Collateral Ligament Injuries: Where Do We Stand in 2024?

Availability

On-Demand

Expires on Sep 30, 2027

Cost

Member: $20.00

Resident/Fellow Member: $20.00

Affiliate Member: $20.00

Non-Member: $30.00

Credit Offered

1.5 CME Credits

1.5 Category A CEU Credits

Course Information
ADDITIONAL INFORMATION

This course includes the recording of a live Instructional Course from the 2024 AOSSM Annual Meeting which took place in Denver, CO.

IC 106: Ulnar Collateral Ligament Injuries: Where Do We Stand in 2024?

Course Description:

Ulnar collateral ligament (UCL) injuries of the elbow are on the rise in overhead athletes of all levels of play. Many of these injuries can be managed non-operatively with rest and a return to throwing program with or without the addition of a biologic to aid in ligament healing. However, a subset necessitates surgical intervention. Surgical techniques have continued to evolve over the past several years and now include a primary UCL repair with internal brace, modified docking technique with added graft strands, and others. Furthermore, as more primary UCL repairs and reconstructions are performed, the number of revision UCL reconstructions has risen proportionally.

The purpose of this ICL is to review the most up-to-date strategies for treatment of UCL injuries including the use of biologics, UCL repair, primary UCL reconstruction, and revision UCL reconstruction. The panel will review several complete cases and will work through each case from diagnosis to management to return to play. The participants will be taken through each case and asked how they would proceed at varying steps in management. The faculty will provide pearls based on their experience in dealing with these difficult cases. We will also discuss our UCL registry that was funded by AOSSM and provide updates.

Learning Objectives:

At the completion of this course, the participant will be able to:

Understand the current risk factors for sustaining an ulnar collateral ligament injury and the most effective prevention strategies.
Understand the breadth of treatment options for ulnar collateral ligament injuries including non-operative management, biologics, repair, reconstruction, and revision.
Develop a treatment algorithm for these injuries based on the best available evidence and understand technical pearls to obtain the best possible outcomes in these patients.

Faculty:

Brandon J. Erickson, MD
Eric N. Bowman, MD, MPH
Peter N. Chalmers, MD
Gregory L. Cvetanovich, MD
Anthony A. Romeo, MD
Mark S. Schickendantz, MD

Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Information

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credits™ participants must complete the activity and evaluation. Please note that this is an online-only activity. Participants must complete the activity and evaluation online. No hard copy submissions will be accepted.

ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

The American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP#: P460) is approved by the Board of Certification, Inc. to provide continuing education for Athletic Trainers. This live activity is eligible for a maximum of 1.5 Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.

Disclosures

Name	Disclosure Details
Bowman, Eric (MD, MPH)	Unpaid Consultant relationship with Innovation Institute
Chalmers, Peter (MD)	Research Support relationship with Smith and Nephew, Depuy; Stock or Stock Options relationship with TitinKM Biomedical; Paid Consultant relationship with Depuy, Exactech, Smith and Nephew, DJO; Speaker's Bureau/Presenter relationship with Depuy, Exactech; Royalties relationship with Depuy, Responsive Arthroscopy, Exactech
Cvetanovich, Gregory (MD)	No Relevant Financial Relationships
Erickson, Brandon (MD)	Paid Consultant relationship with Arthrex; Royalties, Financial or Material Support from Publishers relationship with SLACK; Research Support relationship with Arthrex
Romeo, Anthony (MD)	Stock or Stock Options relationship with Paragen Technologies, Columbus, OH; Royalties, Financial or Material Support from Publishers relationship with Saunders/Mosby-Elsevier; Royalties relationship with Atreon Orthopedics; Royalties relationship with Arthrex, Inc.; Speaker's Bureau/Presenter relationship with Arthrex, Inc.; Research Support relationship with Vertex; Paid Consultant relationship with Arthrex, Inc.
Schickendantz, Mark (MD)	Stock or Stock Options relationship with Lazurite; Paid Consultant relationship with Arthrex

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

ORIGINAL RELEASE DATE: 10/01/2024
EXPIRATION DATE: 09/30/2027